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Executive Summary 
Pyrrolizidine alkaloids (PAs) and their N-oxides (PANOs) are plant toxins which can enter the food 
chain through different paths. Two affected foods are herbal infusions and honey. This proficiency 
testing scheme was executed to assess the capabilities of laboratories to determine PAs. 29 
laboratories from nine EU Member States plus Singapore registered. On 04. and 06.09.2017 test 
items and documentation were dispatched to all of those laboratories. 
By the dead line of 24.10.2017 26 laboratories had reported back results and filled in a 
questionnaire. Test item HO (acacia honey) was fortified with six PAs/PANOs (Echimidine, 
Integerrimine, Intermedine, Senecionine, Seneciphylline-NO, and Senkirkine) and 23 laboratories 
reported results for this item. The same number of laboratories reported for test item HT (herbal 
infusion) which was naturally contaminated with four PAs after extraction under reductive 
conditions (Integerrimine, Retrorsine, Senecionine, and Senecivernine). Laboratories had to report 
the sums of PA and its respective PANO. 
Satisfying outcomes could only be registered for Senecionine in test item HT and for Echimidine, 
Intermedine, and Senkirkine in test item HO with 74 %, 85 %, 85 %, and 91 %, respectively, of 
reported results having a z'-score smaller or equal to |2|. Only four laboratories reported for 
Integerrimine in both test items. Contrary to test item HT, Senecionine analysis in test item HO 
showed very unsatisfactory results. Of the 22 z'-scores calculated for Senecionine nine (41 %) were 
larger than 3. Senecivernine measurements in test item HT showed a similarly unsatisfying outcome 
with 47 % of reported results having z'-scores larger than 3. 
Only three laboratories out of the 26 were able to test for all 10 measurands and only one reported 
all 10 values with z'-scores smaller or equal to |2|. Overall only five laboratories obtained 
satisfactory z'-scores (≤ |2|) for all their reported results. There are two groups of three isomeric 
PAs/PANOs each which apparently caused, for a number of laboratories, problems with 
quantification. This is an issue which deserves heightened attention. 
The questionnaire contained queries regarding accreditation and experience, preparation conditions 
for the two test items, chromatographic separation conditions, detection conditions, calibration 
approach, and a comments section. The answers were evaluated and for selected questions their 
correlation to the z'-score of Senecionine in test item HO or Senecivernine in test item HT was 
analysed. For none of the tested questions a significant influence could be shown. 
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1. Introduction 
Pyrrolizidine alkaloids (PAs) are secondary metabolites of plants used as defence against plant eating 
animals. It is estimated that over 6000 plant species worldwide, mainly from the botanical families 
Boraginaceae (e.g. Heliotropium spp.), Asteraceae (e.g. Senecio spp.) and Fabaceae (e.g. Crotalaria 
spp.), produce at least 600 different PAs. Those with an unsaturated bond in position 1,2 of the 
pyrrolizidine ring system (Figure 1) are hepatotoxic. Additional diversity is created due to oxidation 
of the pyrrolizidine nitrogen to the N-oxide (PANO) which doubles the possible number of PAs. 
 
Figure 1: Structural features of PAs. (A) core structural motif pyrrolizidine (1,2,3,6,7,8-hexahydro-5Hpyrrolizine);(B) 
general description of the main necine base parts of naturally occurring PAs including the common necine base 
numbering; (C) necine base otonecine; a core structural motif of otonecine-type PAs; (D) general pyrrolizine structure 
motif and (E) structural example of 1,2-unsaturated ester PA senecionine (Figure taken from [1]) 
PAs may enter the food chain via different routes. Two possibly affected end products are teas / 
herbal infusions, if PA containing weeds had contaminated the leafs / herbs, and honey, if PA 
containing pollen was collected by the bees. In 2016 the European Food Safety Authority (EFSA) 
published a new scientific report about dietary exposure to PAs [1]. In that report teas / herbal 
infusions were identified as the largest contributors to total PA exposure. It has been recommended 
that for relevant food commodities, as honey and teas / herbal infusions, the effort to collect PAs 
occurrence data should be continued. 
In this PT scheme a naturally contaminated rooibos herbal blend for infusion and a spiked acacia 
honey were sent out to 29 laboratories for PAs analysis. The two test materials were prepared, 
tested for homogeneity, stability, and characterized with respect to contamination level in-house. 
This report presents the results of these tests and characterizations as well as the reported results 
from the participating laboratories.  
2. Scope 
This PT scheme was executed to assess the capabilities of the participating laboratories to determine 
one or more of the following PAs and/or their corresponding PANOs: 
Echimidine, Erucifoline, Europine, Indicine, Integerrimine, Intermedine, Jacobine, Lasiocarpine, 
Lycopsamine, Monocrotaline, Retrorsine, Senecionine, Seneciphylline, Senecivernine, Senkirkine, 
Trichodesmine, 
in an herbal blend for infusion and acacia honey.  
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3. Set-up of PT scheme 
3.1. Time frame 
The PT registration was open from 19.05.2017 to 15.08.2017. Registration could be done 
through a dedicated web site. The test materials were dispatched to the participants on 04.09. 
and 06.09.2017. All shipments reached their respective recipients within 2 days. The initial 
deadline for reporting the results was 20.10.2017. This deadline was eventually extended to 
24.10.2017 because two laboratories reported problems with entering the results. 
3.2. Confidentiality 
The procedures used for the organisation of PTs are accredited according to ISO 17043:2010 [2] 
and guarantee that the identity of the participants and the information provided by them is 
treated as confidential.  
3.3. Distribution 
In all, 29 laboratories from nine EU Member States plus Singapore registered for participation. 
The following was sent to each of them: 
• one container with 40 – 50 g of a herbal blend for infusion naturally contaminated with 
PAs; 
• one container with 50 – 70 g of acacia honey spiked with PAs 
• the "Instructions for PT scheme" letter with the individual reporting password (Annex 1: 
Instructions for PT scheme); 
• the "Proficiency testing materials receipt form" (Annex 2: Proficiency testing materials 
receipt form); 
• a "Submission of results" document explaining the use of the reporting interface. 
3.4. Instructions to participants 
The "Instructions for PT scheme" letter included with the test item shipment gave detailed 
instructions to the participants. In brief, the participants were informed that one or more of the 
following PAs:  
Echimidine, Erucifoline, Europine, Indicine, Integerrimine, Intermedine, Jacobine, Lasiocarpine, 
Lycopsamine, Monocrotaline, Retrorsine, Senecionine, Seneciphylline, Senecivernine, Senkirkine, 
Trichodesmine, 
could be present in either one of the two test items. The participants had to check the test items 
for integrity and store them upon receipt at temperatures between -15 °C and -25 °C. 
Instructions on how to access the reporting web site and how to enter results were also 
included.  
3.5. Standard deviation for proficiency assessment 
Scoring of the reported results was to be done acc. to ISO 13528:2015 and was to be based on 
an independently determined reference value (xPT) for each PA and a target standard deviation 
σPT of 0.22 xPT acc. to the following equation: 
 =  − 	
  
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with xi the reported result of an individual PA from a laboratory. No scoring was to be provided 
for reported sums of total PAs. 
For those analyte contents for which the associated uncertainty of xPT (u(xPT)) was larger than 
0.3 σPT the following equation was used: 
 =  − 	
  
with the adjusted target standard deviation 
 = 
 + 	. 
4. Test items 
4.1. Preparation 
The herbal infusion blend (test material HT, mostly rooibos) was purchased from a provider 
within the EU. It was milled with a ZM200 centrifugal mill with a 0.5 mm sieve (Retsch, Hahn, 
Germany). After thorough homogenization the material was filled into 96 plastic screw-capped 
containers. 
The acacia honey (test material HO) was courtesy of Breitsamer + Ulrich GmbH & Co KG 
(München, Germany). The honey was practically free of PAs (none detected above 3 µg/kg) and 
spiked with Echimidine, Integerrimine, Intermedine, Senecionine, Seneciphylline-NO, and 
Senkirkine. It was then thoroughly mixed with a ploughshare mixer (Lödige, Paderborn, 
Germany) and filled into 73 plastic screw-capped containers. 
4.2. Homogeneity 
For testing the homogeneity ten containers of HT and eight containers of HO were selected. Test 
portions were extracted/cleaned-up with SPE acc. to an internal protocol and measured in 
randomized order with a LC-HRMS. The obtained signals, without conversion to concentration 
units, were evaluated for sufficient homogeneity acc. to ISO 13528 Annex B [3]. More details can 
be found in Annex 3: Homogeneity testing. 
For all analytes in both test materials the results indicated sufficient homogeneity. 
4.3. Stability 
The stability of the analytes in the two test materials was determined through an isochronous 
study. For this purpose randomly selected test units were stored frozen (-15 to –25 °C) and at 
4 °C, and 40 °C for up to eight weeks. At the day of measurement all test units were prepared 
and measured as described for the homogeneity testing. More details can be found in Annex 4: 
Stability testing. 
All analytes in both test materials were sufficiently stable during the PT period. 
5. Assigned values and their uncertainties 
For the scoring of this PT scheme individual mass fractions for all the PAs in the two test materials 
were determined. This was done with gravimetric standard addition using an internal standard 
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(ISTD) acc. to Hauswaldt et al [4]. These measurements were executed in early October for test item 
HT and early November for test item HO. This was due to time constraints and happened without 
prior knowledge of reported results. More details can be found in Annex 5: Determination of the 
assigned values and their uncertainties. 
The assigned values xPT and their associated standard uncertainties u(xPT)  were determined acc. to 
ISO 13528 clause 7 [3] and are listed in Table 1 for test item HT and Table 2 for test item HO. 
6. Evaluation of the results 
6.1. Test item HT 
Test item HT was naturally contaminated with four PAs/PANOs at detectable levels: 
Integerrimine, Retrorsine, Senecionine, and Senecivernine. Table 1 lists relevant parameters. The 
reference values (xPT) are for the sum of PA/PANO after reductive extraction. Since the 
associated uncertainties of the reference values were larger than 0.3 σPT in all cases the 
adjusted target standard deviation σ'PT was used for scoring. The robust mean (x̅rob) was 
computed from the reported results using Algorithm A [3, Annex C] following the 
Recommendation 1 in [5]. A robust mean could not be calculated for the reported results of 
Integerrimine because of too few results and for Senecivernine because of too high a 
contribution of minor modes to the multi-modal distribution of reported results. For the other 
two robust means, the one of Senecionine falls within the expanded uncertainty range (k=2, ~ 95 
% confidence) around xPT , the one of Retrorsine does not. 
For the four PAs present in test item HT a satisfying outcome can only be attested for the 
analysis of Senecionine. It was present at the highest level and 17 out of 23 (74 %) reported 
results showed z'-scores ≤ |2|. No reported result had a z'-score > |3|. At the opposite end is 
the outcome for the measurements of Senecivernine with 47 % of reported results with z'-scores 
larger than 3. For Integerrimine only four laboratories reported a result, two of them as "smaller 
than", even though it was present at the second highest level in this naturally contaminated 
material. Table 3 is listing all reported results and the corresponding z'-scores. The figures in 
Annex 6: Graphs for Test item HT visualise these results. 
Integerrimine, Senecionine, and Senecivernine are three isomeric PAs with the elemental 
formula (C18H25NO5). This makes these three compounds practically indistinguishable for mass 
spectrometry which was the detection mode used by all participating laboratories. Only proper 
chromatographic separation, which is challenging, can provide reliable results for the individual 
compounds. Insufficient separation between Integerrimine and Senecivernine, and false 
identification may have led to the large number of too high results for Senecivernine. A 
compounding factor may be that the majority of participating laboratories were apparently not 
testing for Integerrimine and, therefore, might not have been aware of any coelution issues. 
Integerrimine is not included in the list of PAs provisionally selected by the European 
Commission [1].  
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Laboratory 14 reported to have also detected Senkirkine at 10 µg/kg. No other laboratory 
reported any other PA above its respective LOQ. Laboratory 3 reported the sum of all PAs as 
"retronecine equivalents" at 78 µg/kg. 
Table 1 Parameters of the four PAs and summary of the outcome in test item HT  
 Integerrimine Retrorsine Senecionine Senecivernine 
xPT [µg/kg] 30.6 19.8 80.4 5.7 
u(xPT) [µg/kg] 2.8 1.5 7.8 1.2 
x̅rob [µg/kg]  15.4 65.4  
σPT [µg/kg] 6.7 4.3 17.7 1.2 
u(xPT)>0.3 σPT YES YES YES YES 
σ'PT [µg/kg] 7.3 4.6 19.3 1.7 
Number reported  4 20 23 15 
"<" or ">" 2 7 1 2 
z' ≤ |2| 2 9 17 6 
|2| < z' ≤ |3| 0 2 5 0 
z' > |3| 0 2 0 7 
6.2. Test item HO 
Test item HO was an acacia honey free of PAs. It was spiked with Echimidine, Integerrimine, 
Intermedine, Senecionine, Seneciphylline-NO, and Senkirkine. Table 2 lists relevant parameters. 
These parameters were determined as described for test item HT above. Again, for 
Integerrimine too few results were reported to calculate a robust mean. Of the other robust 
means, the ones for the content of Echimidine and Senkirkine lay within the expanded 
uncertainty ranges (k=2, ~ 95 % confidence) around the respective xPT, the ones for 
Intermedine, Senecionine, and Seneciphylline were below the lower limit of the expanded 
uncertainty ranges. Also, as for test item HT, the associated uncertainties of the reference values 
were larger than 0.3 σPT in all cases but for Senecionine. Yet for reasons of consistency the 
adjusted target standard deviation σ'PT was used for scoring of all PAs including Senecionine. 
Table 2 Parameters of the six PAs and summary of the outcome in test item HO 
 Echimidine Integer-
rimine 
Intermedine Senecionine Seneci-
phylline 
Senkirkine 
xPT [µg/kg] 70.8 54.4 43.9 29.1 12.9 62.1 
u(xPT) [µg/kg] 6.3 3.8 4.4 1.8 1.0 9.6 
x̅rob [µg/kg] 68.4  30.9 23.4 9.7 52.3 
σPT [µg/kg] 15.6 12.0 9.7 6.4 2.8 13.7 
u(xPT)>0.3 σPT YES YES YES NO YES YES 
σ'PT [µg/kg] 16.8 12.6 10.6 6.6 3.0 16.7 
Number reported 20 4 20 22 22 23 
"<" or ">" 1 2 1 1 3 1 
z' ≤ |2| 17 2 17 9 13 21 
|2| < z' ≤ |3| 1 0 2 3 3 0 
z' > |3| 1 0 0 9 3 1 
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Table 3 Reported values and calculated z'-scores for the PAs content in test item HT 
Lab Code Integerrimine Retrorsine Senecionine Senecivernine 
 
reported 
[µg/kg] 
z'-score 
reported 
[µg/kg] 
z'-score 
reported 
[µg/kg] 
z'-score 
reported 
[µg/kg] 
z'-score 
1 
 
 
 
 
 
 
 
 
2 < 10  < 10  75 -0.3 < 5  
3 retronecine equivalents:  78 µg/kg 
4 
 
 17.2 -0.6 59.4 -1.1 8.16 1.5 
5 
 
 15.7 -0.9 47.7 -1.7 12 3.7 
6 < 2  16.58 -0.7 78.08 -0.1 7.84 1.3 
7 
 
 3.7 -3.5 47.9 -1.7 
 
 
8 
 
 11 -1.9 58.14 -1.2 24.4 11.0 
9 
 
 16.92 -0.6 68.21 -0.6 6.86 0.7 
10 
 
 < 10  130 2.6 14.3 5.1 
11 
 
 7.06 -2.8 47.54 -1.7 47.54 24.6 
12 
 
 10.11 -2.1 62.62 -0.9 
 
 
13 21.5 -1.3 11.5 -1.8 38.5 -2.2 8.47 1.6 
14 
 
 < 2.5  64 -0.9 
 
 
15 
 
 20.3 0.1 66.9 -0.7 < 5  
16 
 
 < 2.5  26.6 -2.8 
 
 
17 
 
 < 3  59.2 -1.1 
 
 
18 
 
 
 
 120 2.1 5.9 0.1 
19 
 
 
 
 
 
 
 
 
20 
 
 19.7 0.0 111 1.6 36 17.8 
21 
 
 
 
 30 -2.6 
 
 
22 
 
 < 10  93 0.7 39 19.6 
23 
 
 < 20  < 30  
 
 
24 
 
 35.9 3.5 86.4 0.3 21.2 9.1 
25 
 
 
 
 92.91 0.7 
 
 
26 36.4 0.8 14.8 -1.1 68.3 -0.6 4.9 -0.5 
 
For this test item the measurements of the PAs Echimidine, Intermedine, and Senkirkine showed 
very satisfactory results with 85 % (17 of 20), 85 % (17 of 20), and 91 % (21 of 23), respectively, 
of the z'-scores below or equal to |2|. Analogous to item HT, only four laboratories reported for 
Integerrimine and, contrary to test item HT, the results for Senecionine in this item were very 
unsatisfactory. 
Of the 22 z'-scores calculated for Senecionine nine (41 %) were larger than 3. This is all the more 
surprising since five of those nine laboratories (z'-scores 3.9 to 14.2) scored well for Senecionine 
in item HT (z'-scores -1.7 to 0.7). Additionally, seven laboratories (1, 5, 8, 10, 11, 20, 22) reported 
to have found Senecivernine in item HO and, of these, four scored well in this item for 
Senecionine with z'-scores between -1.0 and 0.9. The results are listed in Table 4 and visualised 
in Annex 6: Graphs for Test item HO. The results for Seneciphylline are also not convincing with 
only 13 out of 22 (59 %) z'-scores below or equal to |2|. 
Laboratories 14 (83 µg/kg) and 19 (30 µg/kg) have reported to have found Lycopsamine and did 
not report results for Intermedine. Intermedine / Lycopsamine / Indicine form another group of 
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isomeric PAs (C15H25NO5) which are difficult to separate. If laboratory 19 which indicated in the 
questionnaire that it reported Intermedine / Lycopsamine / Indicine as sum misidentified 
Intermedine as Lycopsamine then the reported value would have earned a z'-score of -1.3. 
Trichodesmine was reported to have been found by laboratory 12 (49 µg/kg). No other 
laboratory reported any other PA above its respective LOQ. Laboratory 3 reported the sum of all 
PAs as "retronecine equivalents" at 45 µg/kg. 
Correct determination of the individual members of the isomeric groups "Integerrimine / 
Senecionine / Senecivernine" and "Intermedine / Lycopsamine / Indicine" seems to be an issue 
which needs attention. 
Table 4 Reported values and calculated z'-scores for the PAs content in test item HO 
Lab 
Code 
Echimidine Integerrimine Intermedine Senecionine Seneciphylline Senkirkine 
 
repor-
ted 
[µg/kg] 
z'-score 
repor-
ted 
[µg/kg] 
z'-score 
repor-
ted 
[µg/kg] 
z'-score 
repor-
ted 
[µg/kg] 
z'-score 
repor-
ted 
[µg/kg] 
z'-score 
repor-
ted 
[µg/kg] 
z'-score 
1 57.6 -0.8   24.7 -1.8 74.7 6.9 9.1 -1.3 74 0.7 
2             
3 retronecine equivalents:  45 µg/kg 
4 61.8 -0.5   34.4 -0.9 22.7 -1.0 10 -1.0 47.9 -0.9 
5 69.3 -0.1   27.6 -1.5 22.8 -1.0 10.4 -0.8 54.4 -0.5 
6 67.87 -0.2 < 0.5  39.75 -0.4 21.99 -1.1 12.37 -0.2 57.89 -0.3 
7 34 -2.2   32.3 -1.1 83 8.1 25.3 4.1 37.2 -1.5 
8 81.9 0.7   21.4 -2.1 27.6 -0.2 31.7 6.3 60.4 -0.1 
9 72.15 0.1   38.24 -0.5 27.13 -0.3 7.61 -1.8 37.82 -1.5 
10 77 0.4   29.4 -1.4 50 3.1 21.1 2.7 58.2 -0.2 
11 45.92 -1.5   16.84 -2.6 11.07 -2.7 19.71 2.3 42.05 -1.2 
12 69.45 -0.1   29.18 -1.4 58.84 4.5 0.34 -4.2 9.17 -3.2 
13 82.5 0.7 37.4 -1.4 24.8 -1.8 13.6 -2.3 5.78 -2.4 48.9 -0.8 
14       120 13.7 18 1.7 69 0.4 
15 74.6 0.2   30.2 -1.3 19.5 -1.4 10.8 -0.7 49.9 -0.7 
16 62.8 -0.5   33 -1.0 14.5 -2.2 9.9 -1.0 40.4 -1.3 
17     48 0.4 116.33 13.1 < 3  54.73 -0.4 
18 57 -0.8     52 3.4 7.9 -1.7 55 -0.4 
19 122 3.1 < 1    52 3.4 < 1  53 -0.5 
20 96.4 1.5   36.2 -0.7 28.5 -0.1 13.4 0.2 54.7 -0.4 
21 62 -0.5   31 -1.2     44 -1.1 
22 56 -0.9   31 -1.2 35 0.9 9 -1.3 49 -0.8 
23 > 10    > 10  > 10  > 10  > 10  
24             
25     44.49 0.1 54.31 3.8 16.37 1.2 71.75 0.6 
26 74 0.2 39.4 -1.2 57 1.2 16.2 -1.9 10.2 -0.9 49.2 -0.8 
 
6.3. "Smaller than" / "Larger than" values and uncertainties 
For the PAs listed in Table 1 and Table 2 16 results were reported as "smaller than". This 
declaration was only correct for three of the 16. For all others the actual mass fraction was 
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above the "smaller than" value. Five results were reported as "larger than" and all those 
declarations were correct. 
Only for a minority (72 out of 173, i.e. 42 %) of results an associated measurement uncertainty 
was reported. Of those 72 expanded uncertainties 37 were under-estimated, meaning the 
uncertainty ranges around the reported value did not include the reference value. Another five 
reported uncertainty ranges included the value zero meaning the reported value within its 
uncertainty is not different from zero at the selected confidence range. In seven cases the 
estimate of the measurement uncertainty was overly conservative.  
All affected laboratories are advised to check their LOD/LOQ and uncertainty estimations. 
6.4. The questionnaire 
All participating laboratories were asked to fill in a questionnaire addressing their accreditation 
and experience, preparation conditions for the two test items, chromatographic separation 
conditions, detection conditions, calibration approach, and any comments they felt like making. 
Each laboratory reporting results also filled in the questionnaire. For selected questions the 
correlation of answers to the z'-score of Senecionine results in test item HO or Senecivernine 
results in test item HT was analysed by single-factor analysis of variance (ANOVA) after variance 
stabilizing transformation of the response variable.  
The vast majority of the laboratories (85 %) had more than 12 months of experience with PA 
analysis. Two laboratories reported to have less than 3 months and another two between 3 and 
12 months of experience. Accreditation to ISO 17025 for PA analysis was held by 15 laboratories 
while 11 were not accredited. A question begging to be asked is whether holding accreditation 
has a positive effect on the reported results. Looking at the z'-scores of Senecionine results no 
difference in performance between accredited and non-accredited laboratories could be 
detected with ANOVA. The same is true for Senecivernine results. The data is depicted in Figure 
6- 11 in Annex 6: Graphs. 
The information provided about test item preparation showed that the laboratories used a 
median test portion size of 5 g for HO and 2 g for HT. This was then extracted with a median 
volume of 20 mL and 40 mL, for HO and HT, respectively. For both test items the median 
extraction time was 30 min. The composition of the extraction solvents for test item HO was 
either acidic aqueous (16), acidic aqueous/organic (2), neutral aqueous/organic (3), pure organic 
(1), or in one other case basic aqueous/organic. Three laboratories chose to not make a 
statement. For test item HT either acidic aqueous (19), acidic aqueous/organic (2), or neutral 
aqueous/organic (2) conditions were employed. Also here, three laboratories did not make 
statements. Neither for Senecionine results in HO nor for Senecivernine results in HT a 
significant effect of the extraction solvent composition on the z'-scores was detected by ANOVA. 
In the next group of questions about chromatographic separation conditions the 26 laboratories 
all stated to have used liquid chromatography for separation of the PAs/PANOs. Methanol was 
used as organic mobile phase modifier by 19 and acetonitrile by five laboratories. Two 
laboratories did not provide information. Only in two cases the mobile phase did not contain any 
additives. Formate (formic acid with or w/o  ammonium formate) was used by 17 participants, 
acetate (acetic acid with ammonium acetate) by 4, and one laboratory employed a basic mobile 
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phase with ammonium carbonate. Again, two laboratories did not provide information. Neither 
the organic modifier nor the additive in the mobile phase had a significant effect on the results 
of Senecionine in HO or Senecivernine in HT.  
A hypothesis was raised above that the unsatisfactory result for Senecionine in HO was caused 
by insufficient chromatographic separation within the isomeric group "Integerrimine / 
Senecionine / Senecivernine". Ten laboratories reported to have used analytical columns with 
fully porous particles of larger than 2 µm size. The same number of laboratories used sub-2 µm 
fully porous particle columns. Since the sub-2 µm columns are capable of higher separation 
efficiencies it was tested whether that had a significant effect on the scores. But neither for 
Senecionine results in HO nor for the ones of Senecivernine in HT such an effect could be shown.  
All laboratories have used mass spectrometry (MS) for detection with 20 laboratories using 
MS/MS in selected/multiple reaction monitoring (SRM/MRM), one using high resolution MS/MS, 
and three using selected ion monitoring (SIM). Two made no statement. The question how the 
PAs/PANOs were determined was answered by 24 laboratories with individual PAs and PANOs as 
such. One laboratory reduced all PAs/PANOs to a common analyte (retronecine) and derivatised 
with phthalic acid before measurement. And only one laboratory (Lab 19) stated that the sums 
of isomers were reported. 
Questions about the calibration approach were not included in the initial questionnaire. 
Therefore, all 26 reporting laboratories received an email with these questions on 09.11.2017. 
All except one laboratory replied. For the test item HO 24 laboratories reported results and, of 
those, 12 used matrix-matched external standard calibration, six standard addition, three neat 
solvent external standard calibration, one isotope dilution, one "neat solvent external 
standard/standard addition", and one "prespiked matrix matched calibration". The same 
number (24) of laboratories reported at least one result for test item HT. Of those, nine used 
standard addition, six matrix-matched external standard calibration, five neat solvent external 
standard calibration, one isotope dilution, one "neat solvent external standard/standard 
addition", and one "prespiked matrix matched calibration". One of these laboratories did not 
reply to the inquiry. The influence of the calibration approach on the z'-scores for Senecionine in 
HO and Senecivernine in HT was tested with ANOVA and no difference could be found. 
Altogether, 21 laboratories reported results for both test items and only five of them reported 
all their results with satisfactory z'-scores. Laboratory 26 using standard addition reported ten 
values with z'-scores between -1.1 and 2.0. Laboratory 6 reported eight values with scores 
between -1.1 and 1.3 and two "smaller than" results. Laboratory 4 reported eight values with 
scores between -1.1 and 1.5. Both laboratories used matrix-matched external standard 
calibration for test item HO and standard addition for HT. Laboratory 9 reported eight values 
between -1.8 and 0.7 using neat solvent external standard calibration. Finally, laboratory 15 
reported seven values with scores between -1.5 and 0.2 using standard addition and one 
"smaller than" result. 
In the comments section of the questionnaire laboratory 11 declared that it reported the sum of 
Senecionine and Senecivernine. It reported the same value for both in HT. That led to a 
satisfactory z'-score for Senecionine and an unsatisfactory one for Senecivernine. That Indicine 
and Intermedine could not be separated on a C18 column was stated by laboratory 8. Laboratory 
 13 
14 commented that co-occurrence of the isomeric PAs might occur and affect their results. Co-
elution of Lycopsamine and Indicine was remarked by laboratory 16.  
7. Conclusions 
This proficiency testing scheme was executed to assess the capabilities of laboratories to determine 
PAs/PANOs in herbal infusions and honey. 29 laboratories from nine EU Member States plus 
Singapore registered for this PT scheme and were sent two test items for analysis. By the dead line 
of 24.10.2017 26 laboratories had reported back results and filled in a questionnaire.  
Only three laboratories out of the 26 were able to test for all 10 measurands and only one reported 
all 10 values with z'-scores smaller or equal to |2|. Overall only five laboratories obtained 
satisfactory z'-scores (≤ |2|) for all their reported results. The outcome of this scheme points to a 
possible problem by many laboratories to properly determine the individual members of the two 
isomeric groups "Integerrimine / Senecionine / Senecivernine" and "Intermedine / Lycopsamine / 
Indicine".  
For test item HO, spiked with six PAs/PANOs, the measurements of the PAs Echimidine, Intermedine, 
and Senkirkine showed very satisfactory results with 85 % (17 of 20), 85 % (17 of 20), and 91 % (21 of 
23), respectively, of the z'-scores below or equal to |2|. For the four PAs present in test item HT a 
satisfying outcome can only be attested for the analysis of Senecionine. It was present at the highest 
level and 17 out of 23 (74 %) reported results showed z'-scores ≤ |2|. 
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Annex 1: Instructions for PT scheme 
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EUROPEAN COMMISSION 
DIRECTORATE-GENERAL 
JOINT RESEARCH CENTRE 
Directorate F - Health, Consumers & Reference Materials (Geel/Ispra) 
Food & Feed Compliance 
 
Instructions for PT scheme  
"Pyrrolizidine alkaloids contamination in herbal tea and 
honey" 
«AddressBlock» 
 
«GreetingLine» 
please read the following instructions carefully.  
This PT scheme is to assess your laboratory's ability to determine pyrrolizidine alkaloids 
(PAs) in herbal tea and/or honey. The following PAs may or may not be present in the two 
test materials: Echimidine, Erucifoline, Europine, Indicine, Integerrimine, Intermedine, 
Jacobine, Lasiocarpine, Lycopsamine, Monocrotaline, Retrorsine, Senecionine, 
Seneciphylline, Senecivernine, Senkirkine, Trichodesmine.  
It is your choice whether you measure just one or both of the two test materials and which of 
the 16 PAs you determine. You may report a sum parameter combining all PAs or results for 
the individual PAs. If results for individual PAs are reported you must report the sum of the 
amine and the N-oxide of the respective PA. This sum can either be calculated from 
individual values for the amine and N-oxide or it may be the measured value of the total 
amine after reduction of the N-oxide.  
Please check the integrity of the test material containers and use the included material receipt 
form to report back to us your findings as soon as possible. Until commencement of the 
analysis the test materials should be stored at deep freeze temperatures (-15 - -25 °C). Before 
opening the containers they should be given sufficient time to equilibrate to room 
temperature. It is the responsibility of the laboratory to withdraw a representative test portion 
from the test material containers. Therefore, to minimize sub sampling uncertainties, the 
content of the container should be mixed well before withdrawal and the test portion be 
withdrawn in multiple smaller increments. 
Scoring of the reported results will be done acc. to ISO 13528:2015 and be based on an 
independently determined reference value (xPT) for each PA and a target standard deviation 
σPT of 0.22* xPT acc. to the following equation: 
 =  − 	
  
with xi the reported result of an individual PA from a laboratory. No scoring will be provided 
for reported sums of total PAs.
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The reporting deadline is 20. Oct 2017. After this date the reporting interface will be closed.  
Open the following link (https://web.jrc.ec.europa.eu/ilcReportingWeb/) in a web browser 
(preferably use latest version Firefox or Internet Explorer) to enter your results. 
Your personal password key is: «Part_key»  
Enter this into the "Password key" field. 
When entering your results use a "." (dot) as decimal divider. Do not use a "," (comma). To 
enter a result below LOD into the results table select the "<" (smaller as) sign from the drop 
down menu and enter the numerical value of the LOD into the results field. Then choose 
"OTHER, Please specify" in the Technique column and enter "LOD".  
For example, a measurement of Erucifoline with a LOD of 3 µg/kg would be entered as is 
depicted below: 
 
For entering a value below LOQ proceed accordingly. Leave the fields for PAs for which no 
measurements were performed empty. If you determined the sum of all PAs enter your result 
into the top row and leave all others empty. Results entry does not need to happen in one 
session. Entry can always be interrupted. Save what you have entered and come back later to 
continue. Only once you click the "Submit my results" button on the reporting home page the 
entries will be submitted.  
If possible also provide an estimate of the measurement uncertainty and the coverage factor 
used for any reported results larger than LOQ. The annex provides further information on 
how to use the reporting interface. 
There is also a questionnaire about your analysis that we ask you to fill in at the time of 
reporting. 
To prevent falsification of results you must keep the password key confidential. Any attempt 
of collusion is contrary to professional scientific conduct and serves only to nullify the 
benefits of proficiency tests to costumers, accreditation bodies and analysts alike. 
Good luck with your analysis. 
Andreas Breidbach 
PT coordinator 
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Annex 2: Proficiency testing materials receipt form 
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EUROPEAN COMMISSION 
DIRECTORATE-GENERAL 
JOINT RESEARCH CENTRE 
Directorate F - Health, Consumers and Reference Materials 
Food & Feed Compliance  
Geel, 12 December 2017 
 
PROFICIENCY TESTING MATERIALS RECEIPT FORM 
Name: 
Institute: 
 
«Title» «Firstname» «Surname» 
«Organisation» 
 
 
NOTE: STORE MATERIAL IN A FREEZER AT -15 - -25 °C! 
 
Please ensure that the items listed below have been received undamaged, and then 
check the relevant statement: 
 
Date of receipt 
 
 
 
All items have been received undamaged 
 
YES   /   NO  
If NO, please list damaged items: 
 
 
 
 
Contents of the parcel: 
a) 1 container with artificially contaminated honey (HO) 
b) 1 container with naturally contaminated herbal tea (HT) 
c) Instructions with information about storage and reporting 
d) this material receipt form 
 
 
 
Please scan in the completed form and e-mail 
to: 
JRC-EURL-MYCOTOX@ec.europa.eu 
 
Your Signature / Stamp here: 
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Annex 3: Homogeneity testing 
For homogeneity testing of the HT test material 10 test units were randomly selected out of the 96 
test units that were created. Of each of the 10 test units two 1 g test portions were weighed out for 
extraction and clean-up. Care was taken to ascertain that each test portion was representative of its 
respective test unit.  
For homogeneity testing of the HO test material eight test units were selected from the 73 test units 
that were created. Since the test units were created from a more or less continuous material stream 
a random unit was selected from the first 10 units. Then every 10
th
 following unit was selected until 
the end. In this particular case the units 3, 13, 23, 33, 43, 53, 63, and 73 were selected. Of each of 
the selected units 5 g were weighed into a new tube. Then 2.5 g of water were added to reduce 
viscosity of the honey. After thorough mixing two 3 g test portions, representing 2 g test material, 
were weighed into new tubes for clean-up. 
The test portions were extracted/cleaned-up with SPE acc. to an internal protocol and measured in 
randomized order with a LC-HRMS. The obtained signals, without conversion to concentration units, 
were evaluated for sufficient homogeneity acc. to ISO 13528 Annex B [3]. Table 1- 1 shows the 
results for test material HT, Table 1- 2 the results for material HO. 
Table 1- 1: Results of the homogeneity test for test 
material HT 
Analyte c s2s s
2
w 
Integerrimine 0.178 0.0133 0.0905 
Retrorsine 0.0142 0 0.00742 
Senecionine 0.93 0.059 0.55 
Senecivernine 0.00927 0.00234 0.00391 
c- -critical value, s
2
s – between-sample variance, s
2
w – within-
sample variance 
Table 1- 2: Results of the homogeneity test for test 
material HO 
Analyte c s2s s
2
w 
Echimidine 2.74 0 0.310 
Integerrimine 1.08 0 0.0255 
Intermedine 0.558 0.000472 0.0207 
Senecionine 0.272 0.00101 0.00148 
Seneciphylline 0.0493 0.000464 0.000899 
Senkirkine 2.20 0.0221 0.0909 
c- -critical value, s
2
s – between-sample variance, s
2
w – within-
sample variance 
For all analytes in both test materials the between-sample variance was smaller than the critical 
value indicating sufficient homogeneity. 
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Annex 4: Stability testing 
The stability of the analytes in the two test materials was determined through an isochronous study. 
For this purpose randomly selected test units were stored frozen (-15 to –25 °C). Eight weeks before 
the measurement a set of test units was transferred to and stored at 40 and 4 °C, respectively. Four 
weeks before the measurement another set of test units was transferred to and stored at the same 
temperatures. At the day of measurement a set of test units stored frozen, the test units stored for 4 
and 8 weeks at 40 °C, and the test units stored for 4 and 8 weeks at 4 °C were prepared and 
measured as described for the homogeneity testing. The test units stored frozen represented time 
point zero. 
Based on the statistical model with y the measured mass fraction at time point x (in weeks) 
 =  +  
the coefficients β0 and β1 were computed via least square regression. The slope β1 represents the 
analyte change per time unit. If the 95 % confidence range around β1 includes zero there is no 
statistically significant instability. Table 2- 1 shows that this is the case for all analytes in test material 
HT but Retrorsine stored at 40 °C. The temperature level "40 °C" was included to simulate the worst 
case scenario for transportation. All shipments arrived in the respective laboratory within 2 days. 
After reception laboratories were required to store the test materials at deep-freeze temperatures. 
For Retrorsine in HT a 2 day (0.29 weeks) exposure to transportation temperature would result in a 
analyte change of -0.23 ng/g/week * 0.29 weeks = -0.066 ng/g. This is smaller than 0.3 σp (1.2 ng/g) 
and has, therefore, no impact on the calculated z-scores. This is indicated in the right-most column 
of Table 2- 1. 
Table 2- 1: Results of the stability study for test material HT 
Analyte 
Temperature 
[°C] β1 
[ng/g week] 
95 % CR  
[ng/g week] 
β1 × 
max(tT) > 
0.3 σp  
Integerrimine 
4 0.029 -0.75 to  0.81  
40 -0.22 -0.68 to  0.23  
Retrorsine 
4 -0.16 -0.62 to  0.31  
40 -0.23 -0.46 to -0.0032 NO 
Senecionine 
4 0.41 -1.2   to   2.0  
40 -0.77 -1.9   to  0.35  
Senecivernine 
4 -0.092 -0.29 to  0.11  
40 -0.068 -0.23 to  0.10  
β1: contamination change per week, 95 % CR: 95 % confidence range of β1, β1 × max(tT) > 0.3 σp: β1 × 
maximum possible exposure time to respective temperature is larger than 0.3 × target standard 
deviation 
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Table 2- 2: Results of the stability study for test material HO 
Analyte 
Temperature 
[°C] β1 
[ng/g week] 
95 % CR  
[ng/g week] 
β1 × 
max(tT) > 
0.3 σp 
Echimidine 
4 -0.67 -1.2   to -0.16 NO 
40 -0.47 -1.0   to  0.11  
Integerrimine 
4 -0.27 -0.64 to  0.086  
40 0.052 -0.34 to  0.45  
Intermedine 
4 -0.36 -0.69 to -0.028 NO 
40 0.015 -0.29 to  0.32  
Senecionine 
4 -0.11 -0.29 to  0.064  
40 -0.10 -0.35 to  0.15  
Seneciphylline 
4 -0.010 -0.14 to -0.060 NO 
40 -1.2 -1.6   to -0.80 NO 
Senkirkine 
4 -0.026 -0.33 to  0.27  
40 0.073 -0.38 to  0.53  
β1: contamination change per week, 95 % CR: 95 % confidence range of β1, β1 × max(tT) > 0.3 σp: β1 × 
maximum possible exposure time to respective temperature is larger than 0.3 × target standard 
deviation 
Table 2- 2 lists the result for the test material HO. Here for Echimidine and Intermedine a statistically 
significant instability was detected at 4 °C storage but not at 40 °C. But even incorrect storage at 4 °C 
over the 7 week study period would not lead to a contamination change which would affect the z-
score. For Seneciphylline instabilities at both tested temperatures were detected. Assuming a 2-day 
exposure to 40 °C during transportation and 7 weeks of storage at 4 °C an analyte change of 0.41 
ng/g would result. The critical value 0.3* σp is 0.89 ng/g. All of this is indicated in the right-most 
column. 
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Annex 5: Determination of the assigned values and their uncertainties 
This was done with gravimetric standard addition using an internal standard (ISTD) acc. to Hauswaldt 
et al. [4]. In brief, an amount of a mixed PAs solution was gravimetrically added to an aliquot of the 
test material. The mixed PAs solution was prepared from individual PA reference materials of which 
the purity was verified using HPLC, TGA-GC-MS, and qNMR. For the HT test material approx. 15 or 77 
mg were added in duplicate to four aliquots. For the HO test material approx. 27, 56, or 80 mg were 
added to six aliquots in duplicate. Since the HO test material contained Seneciphylline-NO approx. 37 
or 74 mg of a Seneciphylline-NO reference solution were added in duplicate to another four aliquots. 
For each test material two aliquots were prepared without addition of PAs. To all HT aliquots a 
constant amount of approx. 157 mg of an ISTD solution (Heliotrine) was added. To all HO aliquots 
approx. 192 mg ISTD were added. All additions were performed with a calibrated analytical balance 
with a readability of d = 0.01 mg.  
Extraction and clean-up were performed the day after the additions to give the added reference 
materials sufficient time to equilibrate. To this end, H2O/formic acid (95/5, v/v) and zinc were added 
to the aliquots. This created a reductive environment to reduce the N-oxides to the respective 
amines. After 60 min the zinc and other particulate matter were pelleted through centrifugation. 
The supernatant was adjusted to approx. pH 10 with conc. ammonia and an aliquot was cleaned-up 
with SPE. The dried eluate was reconstituted with H2O/formic acid (999/1, v/v) and injected into a 
LC-HRMS. Almost baseline separation was achieved for the critical groups: intermedine/lycopsamine 
and senecivernine/integerrimine/Senecionine (see Figure 5- 1). The reductive extraction was chosen 
to reduce the complexity of the separation and to limit the number of reference materials necessary 
for this task. 
Iteratively weighted least square regression was used to determine the intercept β0 and the slope β1 
of the linear model: 
 =	 +  
with 
R' – ratio of peak area of analyte divided by peak area of ISTD; 
my – mass of the ISTD solution; 
mx – mass of the test material aliquot; 
mz – mass of the mixed PAs solution. 
With β0 and β1 known the mass fraction of the analyte wx can be calculated: 
 =  
with wz the mass fraction of the analyte in the mixed PAs solution. 
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Following the law of error propagation the uncertainty of wx is 
	 = 
 	 − 2 , 	 − 

 	 + 
 	 
with 
u
2(wz) – squared standard uncertainty of the analyte mass fraction in the mixed PAs solution; 
u(β0, β1) – co-variance of the intercept β0 and the slope β1 from the regression; 
u
2(β1) – squared standard error of the slope β1 from the regression; 
u
2(β0) - squared standard error of the intercept β0  from the regression. 
Acc. to ISO 13528:2015 [3] the assigned value for an analyte in a test material is calculated as 
 =  +  !"#" +  $%&' +  %(&)$ 
with 
xPT – the assigned value; 
wx – the reference value determined through standard addition; 
δhomo – error due to possible inhomogeneity (assumed as zero); 
δstab – error due to possible instability during the proficiency test period (assumed as zero); 
δtrans – error due to possible instability under transport conditions. 
Since those errors were negligible they were included into the respective standard uncertainties. The 
associated combined uncertainty is calculated as 
	 = 	 + ℎ++	 + ,-./	 + -0.1,	 
with 
u(xPT) – combined uncertainty of the assigned value; 
u
2(wx) – squared uncertainty of the mass fraction of the analyte; 
u
2(homo) – squared uncertainty of the homogeneity determination incl. possible error; 
u
2(stab) - squared uncertainty of the stability determination incl. possible error; 
u
2(trans) - squared uncertainty due to transport conditions incl. possible error. 
For all analytes u(stab) was calculated as  
,-./	 = 23∑ − 	 × 7 ×  
with 
RSDy – relative standard deviation of all mass fractions determined during the stability study for a 
given analyte; 
xi – individual time points; 
x̅ - average of all time points; 
wx – the reference value determined through standard addition; 
the factor 7 represents the duration of the PT scheme in weeks. 
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For analytes for which a significant instability was detected the values for δtrans and u
2(trans) were 
calculated from the slope β1  and its uncertainty u(β1), respectively, by multiplying with 2/7 
(transportation time of 2 days expressed in weeks). The main contributors to the uncertainty 
budgets of the assigned values were the uncertainties due to the determination of β0 and β1. Table 
3- 1 lists the respective values for test material HT, and Table 3- 2 does the same for test material 
HO. 
 
Table 3- 1: The assigned values and their uncertainties for the test material HT 
Analyte 
xPT 
[ng/g] 
u(wx) 
[ng/g] 
u(homo) 
[ng/g] 
u(stab) 
[ng/g] 
u(trans) 
[ng/g] 
u(xPT) 
[ng/g] 
Integerrimine 30.6 2.8 0.11 0.14 0 2.8 
Retrorsine 19.9 1.5 0 0.099 0.11 1.5 
Senecionine 80.4 7.8 0.24 0.36 0 7.8 
Senecivernine 5.7 1.2 0.048 0.037 0 1.2 
 
Table 3- 2: The assigned values and their uncertainties for the test material HO 
Analyte 
xPT 
[ng/g] 
u(wx) 
[ng/g] 
u(homo) 
[ng/g] 
u(stab) 
[ng/g] 
u(trans) 
[ng/g] 
u(xPT) 
[ng/g] 
Echimidine 71.1 6.3 0 0.099 0.31 6.3 
Integerrimine 54.4 3.8 0 0.076 0 3.8 
Intermedine 44.1 4.4 0.022 0.088 0.16 4.4 
Senecionine 29.1 1.8 0.032 0.036 0 1.8 
Seneciphylline 13.4 1.0 0.021 0.29 0.51 1.2 
Senkirkine 62.1 9.6 0.15 0.086 0 9.6 
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Figure 5- 1 Extracted ion chromatograms of a PA mixed reference solution; the top panel shows the 
separation of Senecivernine / Integerrimine / Senecionine (m/z 336.1805±3 ppm); the bottom panel 
shows the separation of Intermedine / Lycopsamine (m/z 300.1805±3 ppm); Indicine coelutes with 
Lycopsamine under these conditions; separation was afforded by a Phenomenex Kinetex C18 
100x2.1mm, 1.7 µm particle size. 
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Annex 6: Graphs 
 
Test item HT 
 
 
Figure 6- 1 Plot of results for Integerrimine from smallest to largest; black circles – reported results, red circles – 
reported "smaller than", black vertical line – reported measurement uncertainty, green solid line – assigned 
value, green broken line – two times adjusted target standard deviation σ'PT 
 
 
Figure 6- 2 Plot of results for Retrorsine from smallest to largest; black circles – reported results, red circles – 
reported "smaller than", black vertical line – reported measurement uncertainty, green solid line – assigned 
value, green broken line – two times adjusted target standard deviation σ'PT 
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Figure 6- 3 Plot of results for Senecionine from smallest to largest; black circles – reported results, red circles – 
reported "smaller than", black vertical line – reported measurement uncertainty, green solid line – assigned 
value, green broken line – two times adjusted target standard deviation σ'PT 
 
 
Figure 6- 4 Plot of results for Senecivernine from smallest to largest; black circles – reported results, red circles – 
reported "smaller than", black vertical line – reported measurement uncertainty, green solid line – assigned 
value, green broken line – two times adjusted target standard deviation σ'PT 
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Test item HO 
 
 
Figure 6- 5 Plot of results for Echimidine from smallest to largest; black circles – reported results, magenta 
colored circles – reported "larger than", black vertical line – reported measurement uncertainty, green solid line 
– assigned value, green broken line – two times adjusted target standard deviation σ'PT 
 
 
Figure 6- 6 Plot of results for Integerrimine from smallest to largest; black circles – reported results, red circles – 
reported "smaller than", black vertical line – reported measurement uncertainty, green solid line – assigned 
value, green broken line – two times adjusted target standard deviation σ'PT 
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Figure 6- 7 Plot of results for Intermedine from smallest to largest; black circles – reported results, magenta 
colored circles – reported "larger than", black vertical line – reported measurement uncertainty, green solid line 
– assigned value, green broken line – two times adjusted target standard deviation σ'PT 
 
 
Figure 6- 8 Plot of results for Senecionine from smallest to largest; black circles – reported results, magenta 
colored circles – reported "larger than", black vertical line – reported measurement uncertainty, green solid line 
– assigned value, green broken line – two times adjusted target standard deviation σ'PT 
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Figure 6- 9 Plot of results for Seneciphylline from smallest to largest; black circles – reported results, magenta 
colored circles – reported "larger than", red circles – reported "smaller than", black vertical line – reported 
measurement uncertainty, green solid line – assigned value, green broken line – two times adjusted target 
standard deviation σ'PT 
 
 
Figure 6- 10 Plot of results for Senkirkine from smallest to largest; black circles – reported results, magenta 
colored circles – reported "larger than", black vertical line – reported measurement uncertainty, green solid line 
– assigned value, green broken line – two times adjusted target standard deviation σ'PT 
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Questionnaire data 
 
Figure 6- 11 Box & whisker plots of absolute z'-scores of Senecionine results in HO or Senecivernine results in HT 
grouped by whether an accreditation for PA analysis was held by the laboratories; bold horizontal line: median value, 
boxes extend from the first to the third quantile of the data. 
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Annex 7: Questionnaire data 
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Table 7- 1 Answers to questionnaire about experience and accreditation 
Lab 
Code 
Previous 
experience 
ISO 17025 
accredited 
Scope of accreditation Lab 
Code 
Previous 
experience 
ISO 17025 
accredited 
Scope of accreditation 
1 >12 months Yes DAkkS 14 >12 months No  
2 >12 months No 
 
15 >12 months Yes Honey, herbs and tea, grains 
3 >12 months No 
 
16 >12 months No  
4 >12 months Yes tea, honey 17 3-12 months No  
5 0-3 months No 
 
18 0-3 months No  
6 >12 months Yes 
flexible scope, determination of contaminants, 
plant toxins and mycotoxins by LC-MS/MS 
19 >12 months No  
7 >12 months Yes Food 20 >12 months Yes DAkkS Number D-PL-XXXXX-01-00, flexible 
8 >12 months No 
 
21 >12 months Yes 
See on the DAKKS website under our accreditation 
number: D-PL-XXXXX-01-00 
9 >12 months Yes HPLC-MS/MS 22 >12 months Yes 
Bee Products, Honey, Plant materials, tea and 
herbal tea, spices, feed 
10 >12 months Yes food (tea, herbal tea, spices) 23 >12 months No  
11 >12 months Yes 
 
24 3-12 months Yes D-PL-XXXXX-01-00 
12 >12 months Yes Tea, herbal Tea, Honey 25 >12 months Yes HONEY 
13 >12 months Yes flexible accreditation 26 >12 months No  
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Table 7- 2 Answers to questionnaire about treatment of test item HO (Labs 1-13) 
Lab 
Code 
HO test 
portion 
size [g] 
HO 
extractant 
HO  
extractant 
simplified 
HO 
extractant 
vol. [mL] 
HO  
extraction time 
[min] 
HO  
cleaned 
up? 
HO  
Clean-up type 
HO  
calibration mode  
1 5 water/acetonitrile aqu/org 20 30 Yes 
QuEChERs MIX I: MgSO4, NaCl, Na2H Citrate,  
Na3 Citrate; QuEChERS MIX III: Diamino, MgSO4 
 
2 0 N/A 
   
No 
 
N/A 
3 0.2 0.05 mol/l H2SO4 aqu/acidic 5 720 Yes SCX-SPE isotope dilution 
4 2 0.05 mol/l H2SO4 aqu/acidic 10 15 Yes SPE matrix-matched external STD 
5 1.5 H2SO4 0,1M and ACN aqu/org/acidic 10 30 Yes QUECHERS neat solvent external STD 
6 5 0.05 mol/l H2SO4 aqu/acidic 30 10 Yes HR-X (Macherey Nagel, C18) matrix-matched external STD 
7 10 0.05 mol/l H2SO4 aqu/acidic 30 30 Yes SPE with HF Bond Elut LRC-SCX matrix-matched external STD 
8 10 0.05 mol/l H2SO4 aqu/acidic 30 30 Yes SPE cartridge SCX 500 mg matrix-matched external STD 
9 2 Water, H2SO4 aqu/acidic 40 20 Yes filter neat solvent external STD 
10 5 0.05 mol/l H2SO4 aqu/acidic 50 15 Yes SPE with Chromabond HR-X standard addition 
11 2 2 % formic acid aqu/acidic 40 30 Yes centrifugated, filtered, SPE clean-up matrix-matched external STD 
12 10 0.05 mol/l H2SO4 aqu/acidic 30 30 Yes 
Cation exchange (HF Bond Elut LRC-
SCX, 500 mg) 
matrix-matched external STD 
13 5 
acetonitrile (adjusted to 
alkaline pH w/ ammonia 
solution) 
aqu/org/basic 10 10 No 
 
matrix-matched external STD 
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Table 7- 3 Answers to questionnaire about treatment of test item HO (Labs 14-26) 
Lab 
Code 
HO test 
portion 
size [g] 
HO 
extractant 
HO  
extractant 
simplified 
HO 
extractant 
vol. [mL] 
HO  
extraction time 
[min] 
HO  
cleaned up? 
HO  
Clean-up type 
HO  
calibration mode  
14 5 
acetonitrile:water, 1:1 
(QuEChERS-like method) 
aqu/org 20 2 No 
 
matrix-matched external STD 
15 0.5 
Acetonitrile : Methanol : 
Water 1:1:1 (v:v:v) 
aqu/org 10 15 No 
 
neat solvent external STD / 
standard addition 
16 5 
20 g NaCl in 800 ml H2O, 
making up to 1 L with HCl 
37% 
aqu/acidic 20 60 No 
 
neat solvent external STD 
17 10 0.05 mol/l H2SO4 aqu/acidic 30 30 Yes MCX SPE_Waters 
Prespiked matrix matched 
calibration 
18 1 0.1 n HCl in Water aqu/acidic 20 60 Yes NH2 matrix-matched external STD 
19 4 
Hydrochloricacid and 
Acetonitrile 
aqu/org/acidic 8 10 Yes MgSO4 and PSA matrix-matched external STD 
20 1 
aqueous citric buffer 
solution 
aqu/acidic 25 15 Yes Solid phase extraction matrix-matched external STD 
21 10 no further information  0 0 Yes no further information standard addition 
22 1 Acetonitrile org 4 6 Yes liquid liquid extraction standard addition 
23 10 0.05 mol/l H2SO4 aqu/acidic 30 30 Yes SPE Bond Elut LRC SCX 500mg matrix-matched external STD 
24 0 not 
 
0 0 No 
  
25 20 0.05 mol/l H2SO4 aqu/acidic 200 30 Yes SCX SPE CARTRIDGE standard addition 
26 2 0.2% formic acid in water aqu/acidic 20 30 Yes 
Solid Phase Extraction on 
Phenomenex Strata X 200 mg/6 ml 
standard addition 
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Table 7- 4 Answers to questionnaire about treatment of test item HT (Labs 1-13) 
Lab 
Code 
HT test 
portion 
size [g] 
HT  
extractant 
HT  
extractant 
simplified 
HT 
extractant 
vol. [mL] 
HT  
extraction time 
[min] 
HT  
cleaned up? 
HT  
Clean-up type 
HT  
calibration mode  
1 0 not analyzed 
 
0 0 No 
 
N/A 
2 2 acetic acid and methanol aqu/org/acidic 20 23 No 
 
standard addition 
3 0.1 0.05 mol/l H2SO4 aqu/acidic 5 720 Yes SCX-SPE isotope dilution 
4 10 0.05 mol/l H2SO4 aqu/acidic 200 15 Yes SPE standard addition 
5 1 0.05 mol/l H2SO4 aqu/acidic 25 30 Yes SPE MCX neat solvent external STD 
6 2 0.05 mol/l H2SO4 aqu/acidic 40 30 Yes HR-X (Macherey Nagel, C18) standard addition 
7 2 0.05 mol/l H2SO4 aqu/acidic 40 30 Yes SPE with DSC-C18 SPE (Supelco) neat solvent external STD 
8 2 0.05 mol/l H2SO4 aqu/acidic 40 30 Yes SPE DSC C18 standard addition 
9 2 Water, H2SO4 aqu/acidic 40 20 Yes filter neat solvent external STD 
10 2.5 0.05 mol/l H2SO4 aqu/acidic 50 30 Yes SPE with Chromabond HR-X standard addition 
11 2 2 % formic acid aqu/acidic 40 30 Yes centrifugated, filtered, SPE clean-up matrix-matched external STD 
12 2 0.05 mol/l H2SO4 aqu/acidic 20 15 Yes 
C18-SPE (Discovery DSC18, 6 ml, 500 
mg) 
neat solvent external STD 
13 2 0.05 mol/l H2SO4 aqu/acidic 40 15 Yes SPE (C18-ec) matrix-matched external STD 
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Table 7- 5 Answers to questionnaire about treatment of test item HT (Labs 14-26) 
Lab 
Code 
HT test 
portion 
size [g] 
HT  
extractant 
HT  
extractant 
simplified 
HT 
extractant 
vol. [mL] 
HT  
extraction time 
[min] 
HT  
cleaned up? 
HT  
Clean-up type 
HT  
calibration mode  
14 2 
acetonitrile:water, 1:1 
(QuEChERS-like method) 
aqu/org 20 30 No 
 
matrix-matched external STD 
15 0.5 
Acetonitrile : Methanol : 
Water 1:1:1 (v:v:v) 
aqu/org 10 15 No 
 
neat solvent external STD / 
standard addition 
16 2.5 
20 g NaCl in 800 ml H2O, 
making up to 1 L with 
HCl 37% 
aqu/acidic 25 60 No 
 
neat solvent external STD 
17 2 0.05 mol/l H2SO4 aqu/acidic 50 30 Yes MCX SPE waters 
Prespiked matrix matched 
calibration 
18 0.5 0.1 n HCl in Water aqu/acidic 20 60 Yes GCB matrix-matched external STD 
19 4 
Hydrochloricacid and 
Acetonitrile 
aqu/org/acidic 8 10 No 
 
NA 
20 1 
aqueous citric buffer 
solution 
aqu/acidic 25 15 Yes Solid phase extraction matrix-matched external STD 
21 1 no further information  0 0 Yes no further information standard addition 
22 2 no further information  0 0 Yes no further information standard addition 
23 2 0.05 mol/l H2SO4 aqu/acidic 40 30 Yes SPE DSC-C18 (Supelco) 500mg matrix-matched external STD 
24 2 Water+sulfuric acid aqu/acidic 20 15 Yes SPE 
 
25 1 
0.2% formic acid in 
water 
aqu/acidic 40 30 Yes 
Solid Phase Extraction on 
Phenomenex Strata X 200 mg/6 ml 
standard addition 
26 2 
0.2% formic acid in 
water 
aqu/acidic 40 30 Yes 
Solid Phase Extraction on 
Phenomenex Strata X 200 mg/6 ml 
standard addition 
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Table 7- 6 Answers to questionnaire about separation conditions (Labs 1-13) 
Lab 
Code 
Separation method Sep. meth. 
other 
Analytical column Mobile phase Flow rate 
[ml/min] 
1 Liquid chromatography  
C18, 50 mm, 2,0 mm, 2µm (YMC Ultra Hydrosphere 
50*2,0mm; ( Partikel 2µm) (Poren 12mm) 
eluent A: distilled water (1 %CH3COOH, 0,05 % 10 M NH4(HCOO)) ; 
eluent B: methanol (1 %CH3COOH, 0,05 % 10 M NH4(HCOO)) 
0.2 
2 Liquid chromatography  Thermo Hypersil Gold C18; 150x2,1mm water and methanol 0.3 
3 Liquid chromatography  Synergi Max-RP 4um, 150 x 2 mm H2O/ACN Gradient, each phase containing 0.3 % formic acid 0.3 
4 Liquid chromatography  C18, 150 x 2.0 mm water/acetonitrile with ammonium formiate and formic acid 0.3 
5 Liquid chromatography  Luna C8 150 x 2 mm 3 ?m ammonio formiate in H2O and ammonio formiate in MeOH 0.25 
6 Liquid chromatography  C18, 100mm, 2,1mm, 1,8 ?m (Eclipse Plus ) A: Methanol+0,1% FA B: Wasser+0,1% FA 0.3 
7 Liquid chromatography  Kinetex C18, 100 mm, 2.1 mm, 2,6 µm 
5 mM NH4COO and 0.1% COOH in water/ 5 mM NH4COO and 
0.1% COOH in methanol 
0.2 
8 Liquid chromatography  C18, 200 mm, 2.1 mm, 1.9 µm, Hypersil Gold 
water / Methanol with HCOOH 0.1% and ammonium formiate 315 
mg/l 
0.25 
9 Liquid chromatography  N/A N/A 0.4 
10 Liquid chromatography  Acquity UPLC BEH C18 1,7 µm, 2,1 x 100 mm ammonium formiate + formic acid in water / methanol 0.2 
11 Liquid chromatography  Waters, ACQUITY UPLC BEH C18 150 x 2,1 mm 1,7 µm 0,1 % formic acid in water; 0,1 % formic acid in acetonitrile 0.2 
12 Liquid chromatography  RP18 (Kinetex 2.6 µ EVO C18 100A, 150 * 2.1 mm) Gradient H2O and MeOH (both 5 mM NH4HCO2 and 0.1% CH2O2) 0.35 
13 Liquid chromatography  Waters BEH C18 (1.7 µm, 100 mm, 2.1 mm ID) 
A: 0.005 M ammonium formate / formic acid in water (pH 3); B: A: 
0.005 M ammonium formate / formic acid in methanol (pH 3) 
0.35 
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Table 7- 7 Answers to questionnaire about separation conditions (Labs 14-26) 
Lab 
Code 
Separation method Sep. meth. 
other 
Analytical column Mobile phase Flow rate 
[ml/min] 
14 Liquid chromatography  
silica-based reversed-phase (C18) analytical column 
Acquity UPLC HSS T3 (lenght 100 mm, 2.1 mm inner 
diameter, 1.8 um particle size) 
5mM ammonium formate and 0.2% formic acid both in methanol 
(A) and milli-Q water (B) 
0.3 
15 Liquid chromatography  Waters Acquity UPLC BEH C18 1.7µm 2.1 x 150 mm water : methanol + ammoniumformiat and formic acid 0.3 
16 Liquid chromatography  
Phenomenex Kinetex 2.6 ?m XB-C18 column (100 × 4.6 
mm) 
MPA: H2O + 5 mM ammonium acetate + 0.05% acetic acid; MPB: 
acetonitrile 
1.5 
17 Other LCMS-MS C18,100mm,2.1um,3um 5mM ammonium acetate ,0.1% formic acid in MeOH/water 0.4 
18 Liquid chromatography  
Agilent InfinityLab Poroshell 120 EC-C18,2.1 × 100 mm, 
2.7 µm (p/n 695775-902) with HPLC, Guard (p/n 821725-
911) at 25 °C 
0.025 % formic acid in 5 mM ammonium formate in Water (A), 
0.025 % formic acid 5 mM ammonium formate in methanol (B), 
0.3 
19 Liquid chromatography  150mm*2mm, C18 Methanol/ammonium acetate 0.15 
20 Liquid chromatography  
Thermo Scientific TM Hypersil Gold C18 150 x 3 mm, 3 µm 
particle size 
A: methanol + 5 mmol ammonium formate + 1% formic acid; 
B:water + 5 mmol ammonium formate + 1% formic acid 
0.4 
21 Liquid chromatography 
no further 
informa-
tion 
no further information no further information 0 
22 Liquid chromatography  C18, 150mm, 2.1mm, 5µm formic acid in water / formic acid in methanol 0.3 
23 Liquid chromatography  Acclaim Vanquish PA2, 150 x 2.1 mm, 2.2 um particle size 
A: Ammonium formate (315mg/L): formic acid (1ml/L) in water; B: 
Ammonium formate (315mg/L): formic acid (1ml/L) in methanol 
0.3 
24 Other LC MS/MS Hypersil gold 150 x 2,1mm; 175A, 3µm Eluent A: Water Eluent B: Methanol 0.3 
25 Liquid chromatography  C18, 150MM, 2.1MM,1.9UM 
A:5mM AMMONIUM FORMATE, 0.1% FORMIC ACID IN 
METHANOL; B: 5mM AMMONIUM FORMATE, 0.1% FORMIC ACID 
IN ULTRAURE WATER 
0.3 
 40 
26 Liquid chromatography  Waters BEH C18, 150 x 2.1 mm, 1.7 um A: 10 mM ammonium carbonate in water (pH 9.0), B: acetonitrile 0.4 
Table 7- 8 Answers to questionnaire about detection conditions (Labs 1-13) 
Lab 
Code 
Detector Ioniza-
tion 
mode 
Ionization 
mode 
other 
MS mode PAs 
determined as 
PANOs  
determined as 
Other Deriva-
tization? 
Which deriv. 
1 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
2 Mass spectrometry ESI 
 
SRM Individual PAs measured as such 
 
No 
 
3 Mass spectrometry ESI 
 
MRM 
Sum after 
conversion of 
PAs to 
common 
analyte 
reduced to the 
amine before 
separation 
 Yes 
Phthalic acid 
anhydrid 
4 Mass spectrometry ESI 
 
SRM Individual PAs measured as such 
 
No 
 
5 Mass spectrometry ESI 
 
SRM Individual PAs measured as such 
 
No 
 
6 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
7 Mass spectrometry ESI 
 
sMRM Individual PAs measured as such 
 
No 
 
8 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
9 Mass spectrometry ESI 
  
Individual PAs measured as such 
 
No 
 
10 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
11 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
12 Mass spectrometry ESI 
 
MRM Individual PAs measured as such 
 
No 
 
13 Mass spectrometry ESI 
 
dynamic 
MRM 
Individual PAs measured as such 
 
No 
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Table 7- 9 Answers to questionnaire about detection conditions (Labs 14-26) 
Lab 
Code 
Detector Ioniza-
tion 
mode 
Ionization 
mode 
other 
MS mode PAs 
determined as 
PANOs  
determined as 
Other Deriva-
tization? 
Which deriv. 
14 Mass spectrometry ESI n HRMS/MS Individual PAs measured as such 
 
No 
 
15 Mass spectrometry ESI n MRM Individual PAs measured as such 
 
No 
 
16 Mass spectrometry ESI n SRM Individual PAs measured as such  No 
 
17 Mass spectrometry ESI n MRM Individual PAs measured as such 
 
No 
 
18 Mass spectrometry ESI n SRM Individual PAs measured as such 
 
No 
 
19 Mass spectrometry Other EI SIM Other measured as such 
some as individual, some as sum of several PA 
(eg. Lycopsamin/Indicin/Intermedin) 
No 
 
20 Mass spectrometry ESI n SIM Individual PAs measured as such 
 
No 
 
21 Mass spectrometry Other 
no further 
informatio
n 
no further 
informatio
n 
Individual PAs measured as such 
 
TRUE 
 
22 Mass spectrometry ESI n SRM Individual PAs measured as such 
 
No 
 
23 Mass spectrometry ESI 
ESI positive 
mode 
SIM Individual PAs measured as such 
 
No 
 
24 Mass spectrometry ESI n SRN Individual PAs measured as such 
 
No 
 
25 Mass spectrometry ESI n MRM Individual PAs measured as such 
 
No 
 
26 Mass spectrometry ESI n MRM Individual PAs measured as such 
 
No 
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Table 7- 10 Comments from Labs 1-13 
Lab 
Code 
Comments 
1 
 
2 
 
3 
 
4 
 
5 
I haven't the Indicine and Integerrimine standards, so I could't resolve these PAs from its isomers (Intermedine/Lycopsamine and Senecionine/Senecivernine). The sum of all PAs is 
the sum of the only PAs with a concentration >LOQ (the other PAs are considered as 0 ppb) 
6 Indicine and Integerrimine are not part of our method 
7 The Concentration and composition of the honey sample did not match our common samples (Concentration too high and too much N-Oxides) 
8 indicine or intermedine are not separated on a C18 column 
9 N/A 
10 
 
11 
On mass transiotion of Senecionone-NO we recognized a Peak with shifted retention time to Senecionine NO Peak. It also has differing ion rations. The Peak is poparbly a different PA 
for which we do not ahve any standard. The transiotions are typical for PA. Results of Senecivernine adn Senecionine are reported as the sum of both. 
12 N/A 
13 Wouldn't it have been wiser to report individual PA results and summarize them subsequently? 
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Table 7- 11 Comments from Labs 14-26 
Lab 
Code 
Comments 
14 Under conditions described within the PT, several PAs were difficult to resolve chromatographically and spectrometrically (lycopsamine x indicine x intermedine; senecionine x 
integerrimine x senecivernine; retrorsine x jacobine); the reported results might be therefore affected by the co-occurrence of these PAs. 
15 Low amounts of Senecivernin and the respectiv N-oxide, just below the respectiv LOQs where found in the herbal tea. Reporting as the sum of amine and the respective N-oxide is 
disadvantageous to accuracy and comparability. 
16 The results are reported as sum of PA and its corresponding N-oxide, however, echimidine-N-oxide, intermedine-N-oxide, lycopsamine-N-oxide were not measured. Under our LC 
conditions there is co-elution of lycopsamine and indicine. HT material: a peak interfering with senecionine-N-oxide prevented proper peak integration, therefore result for this PANO 
is not reported. 
17  
18 LOQs: very strong dependence on matrix components 
19  
20 Meaning of "coverage factor" is unclear. 
21 Section 3.3., 3.4., 4.3., 4.4., 5.4., 5.5.2 no further information 
22  
23 Methods used were the BfR methods for honey and plant material. Tea sample was extracted as 2 x 20ml extrcation solvent for 15 min each extraction. 
24 only tea, sum of amine and N-oxide 
25 ION RATIO DISTORTION OBSERVED FOR RETRORSINE-N-OXIDE IN TEA SO VALUE FOR RETRORSINE NOT REPORTED. ION RATION DISTORTION WAS ALSO OBSERVED FOR ECHIMIDINE 
IN HONEY. 
26 Quantification was performed by means of standard addition to the sample and using internal standard correction 
 
 44 
Annex 8: Participating laboratories 
 
Organisation Part. key Firstname Surname Country 
Agri-Food and Veterinary Authority of Singapore PLA11131621 Lim Poh Choo SINGAPORE 
Austrian Agency for Health and Food Safety CCAK1172028 Christoph Czerwenka AUSTRIA 
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit GFBS1348628 Franziska Gaßmann GERMANY 
Chemical and Veterinary Analytical Institute Muensterland-Emscher-Lippe KOC41110468 Oliver Keuth GERMANY 
Chemisches und Veterinäruntersuchungsamt Ostwestfalen-Lippe AEC41082382 Elisabeth Apel GERMANY 
CVUA Stuttgart KTC10323649 Thomas Kapp GERMANY 
Eurofins Dr. Specht Laboratorien GmbH SEEQ1345165 Edda Sassen GERMANY 
Fera Science Ltd. MSFF1153945 Susan MacDonald UNITED KINGDOM 
FoodQS GmbH RNF12432073 Nadine Raum GERMANY 
Gesellschaft für Bioanalytik mbH JSG11185486 Stefan Jäger GERMANY 
HEALTH SCIENCES AUTHORITY LAHF1128167 Angela Li SINGAPORE 
Intertek Food Services GmbH Bremen ZHI12913009 Hauke Zinow GERMANY 
IZSLER CEIC1078150 ELISABETTA CAPRAI ITALY 
Landesbetrieb Hessisches Landeslabor (LHL) KJL13694049 Johannes Kemme GERMANY 
Landesuntersuchungsamt Rheinland-Pfalz KSLI1049678 Simone Kasper GERMANY 
Lower Saxony State Office for Consumer Protection and Food Safety DKL12243546 Kay Dietrichkeit GERMANY 
PiCA GmbH RAPF1342087 Anna Romanotto GERMANY 
PMA Sindelfingen GmbH GSP10165902 Stefan Glöckler GERMANY 
QSI - Quality Services International GmbH & Co.KG WTQQ1279373 Tobias Wiezorek GERMANY 
RIKILT Wageningen University & Research MHRN1018129 Hans Mol NETHERLANDS 
SCL laboratoire de Strasbourg GLSV1151252 Ledoux Gérald FRANCE 
SGS Germany GmbH MNS12889924 Nicolaus Mouillard GERMANY 
Teekanne GmbH & Co.KG BATL1197037 Andreas Bollert GERMANY 
TU Braunschweig BTTI1231664 Till Beuerle GERMANY 
University of Chemistry and Technology Prague KVUF1247054 Vladimir Kocourek CZECH REPUBLIC 
Veterinary and Agrochemical Research Centre (CODA-CERVA) MSVT1247439 Svetlana Malysheva BELGIUM 
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